Evidence map›Paper›PMID 40006997›Full record

ArticleViruses2025

Enterovirus D68 Subgenotype B3 Circulation in Children with Acute Respiratory Illness in the State of Alagoas, Brazil.

Alex Ranieri Jerônimo Lima, Hazerral de Oliveira Santos, James Siqueira Pereira, Anderson Brandão Leite, Jean Phellipe Marques do Nascimento, Juliana Vanessa Cavalcante Souza, Marlon Breno Zampieri Lima, Mykaella Andrade de Araújo, Marta Giovanetti, Esper Georges Kallas and 3 more

Abstract read
In one paragraph

Article in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Alex Ranieri Jerônimo LimaCenter for Viral Surveillance and Serologic Evaluation (CeVIVAs), Butantan Institute, Av. Vital Brasil 1500, São Paulo CEP 05585-000, Brazil.ORCID 0000-0002-5283-7502
Hazerral de Oliveira SantosCentral Laboratory of Public Health (LACEN)-Alagoas, Rua Ernesto Gomes Maranhão 1773, Maceio CEP 57036-860, Brazil.
James Siqueira PereiraCenter for Viral Surveillance and Serologic Evaluation (CeVIVAs), Butantan Institute, Av. Vital Brasil 1500, São Paulo CEP 05585-000, Brazil.ORCID 0000-0003-1893-8956
Anderson Brandão LeiteCentral Laboratory of Public Health (LACEN)-Alagoas, Rua Ernesto Gomes Maranhão 1773, Maceio CEP 57036-860, Brazil.ORCID 0000-0003-2071-2016
Jean Phellipe Marques do NascimentoCentral Laboratory of Public Health (LACEN)-Alagoas, Rua Ernesto Gomes Maranhão 1773, Maceio CEP 57036-860, Brazil.ORCID 0000-0002-2383-4871
Juliana Vanessa Cavalcante SouzaCentral Laboratory of Public Health (LACEN)-Alagoas, Rua Ernesto Gomes Maranhão 1773, Maceio CEP 57036-860, Brazil.ORCID 0000-0003-1455-4883
Marlon Breno Zampieri LimaPost-Graduation Program in Clinical Oncology, Stem Cells and Cell Therapy, Faculty of Medicine of Ribeirão Preto, University of São Paulo-USP, Av. Bandeirantes 3900, Ribeirão Preto CEP 14049-900, Brazil.
Mykaella Andrade de AraújoCentral Laboratory of Public Health (LACEN)-Alagoas, Rua Ernesto Gomes Maranhão 1773, Maceio CEP 57036-860, Brazil.
Marta GiovanettiSciences and Technologies for Sustainable Development and One Health, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo 21, 00128 Roma, Italy.ORCID 0000-0002-5849-7326
Esper Georges KallasCenter for Viral Surveillance and Serologic Evaluation (CeVIVAs), Butantan Institute, Av. Vital Brasil 1500, São Paulo CEP 05585-000, Brazil.
Sandra Coccuzzo SampaioCenter for Viral Surveillance and Serologic Evaluation (CeVIVAs), Butantan Institute, Av. Vital Brasil 1500, São Paulo CEP 05585-000, Brazil.
Maria Carolina EliasCenter for Viral Surveillance and Serologic Evaluation (CeVIVAs), Butantan Institute, Av. Vital Brasil 1500, São Paulo CEP 05585-000, Brazil.ORCID 0000-0002-0501-8280
Svetoslav Nanev SlavovCenter for Viral Surveillance and Serologic Evaluation (CeVIVAs), Butantan Institute, Av. Vital Brasil 1500, São Paulo CEP 05585-000, Brazil.ORCID 0000-0003-0805-6140

Funding

CNPq 403075/2023-8FAPESP 17/23205-8, 21/11944-6
6 · The paper itself

Abstract

Enterovirus D68 (EV-D68) is a leading cause of acute respiratory disease outbreaks, especially among children. EV-D68 infections can rapidly progress to severe clinical complications and potentially fatal outcomes. In Brazil, no diagnostic or genomic surveillance of this virus is currently performed. Between July and September 2023, cases of acute EV-D68 infection were identified among pediatric patients in several municipalities within the State of Alagoas, Northeast Brazil. Infections were confirmed by RT-qPCR using nasopharyngeal samples, and the complete EV-D68 genomes were sequenced and analyzed through phylogenetic inference. EV-D68 RNA was identified in four children aged 1-9 years from four geographically distinct municipalities in Alagoas. All infections were associated with lower respiratory tract symptoms, including dyspnea and wheezing; however, no fatalities were reported. Complete genomic sequencing revealed that the samples belonged to genotype B, subgenotype B3. This is the first study to report complete genomic data on EV-D68 infections from Brazil and South America. Enhanced genomic surveillance and focused EV-D68 diagnosis are critical to better understanding and managing the regional and national dissemination of this virus.

Indexed as

Enterovirus D, HumanEnterovirus InfectionsRespiratory Tract InfectionsAcute DiseaseBrazilChildChild, PreschoolFemaleGenome, ViralGenotypeHumansInfantMaleNasopharynxPhylogenyRNA, ViralRNA, ViralBrazilEnterovirus D68EV-D68genotype Bpediatric patientsphylogeny

Identifiers

PMID40006997
PMCPMC11860543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.